Diana Hausman

Chief Medical Officer, Cascadian Therapeutics, Inc.

Companies

Immuneering CorpBoard member Jan 18, 2022 to now¹
Zentalis Pharmaceuticals, Inc.Chief Medical Officer Feb 5, 2024 to May 9, 2024²
Zentalis Pharmaceuticals, Inc.Board member May 10, 2023 to May 10, 2023³
ZymeworksChief Medical Officer Jan 2, 2019 to Mar 12, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zentalis Pharmaceuticals, Inc. ZNTL373,876 shares⁵$856.2K at $2.29May 9, 2024
Immuneering Corp IMRX5,500 shares⁶$20.0K at $3.63Jul 2, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 2, 2025Bought 3,000 shares at $3.62 of Immuneering Corp⁶
Jul 2, 2025Bought 2,500 shares at $3.60 of Immuneering Corp⁶
May 9, 2024Sold 3,356 shares at $12.62 of Zentalis Pharmaceuticals, Inc.⁵
Feb 1, 2024Granted 337,500 shares of Zentalis Pharmaceuticals, Inc.⁷
May 8, 2023Granted 39,732 shares of Zentalis Pharmaceuticals, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARImmuneering Corp, Board member
2
SEC EDGARZentalis Pharmaceuticals, Inc., Chief Medical Officer
3
SEC EDGARZentalis Pharmaceuticals, Inc., Board member
4
SEC EDGARZymeworks, Chief Medical Officer
5
SEC EDGARZentalis Pharmaceuticals, Inc. shares after the filing of May 9, 2024
6
SEC EDGARImmuneering Corp shares after the filing of Jul 2, 2025
7
SEC EDGARForm 4 filed Feb 5, 2024
8
SEC EDGARForm 4 filed May 10, 2023